Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 12, 2006, Pages 4616-4621

  Nakai, Kozo ^a   Kadiiska, Maria B ^a   Jiang, Jin Jie ^a   Stadler, Krisztian ^a   Mason, Ronald P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Lipopolysaccharide; Mouse skin

Indexed keywords

3 NITROTYROSINE; ACETAMIDINE DERIVATIVE; ALLOPURINOL; AMINOGUANIDINE; CHELATING AGENT; DEFEROXAMINE MESYLATE; DIMETHYL SULFOXIDE; FERRIC ION; FREE RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N (3 AMINOMETHYL)BENZYLACETAMIDINE; N TERT BUTYL ALPHA (4 PYRIDYL 1 OXIDE) NITRONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; WESTERN BLOTTING;

ALLOPURINOL; ANIMALS; DERMATITIS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; FREE RADICALS; GUANIDINES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; SKIN; XANTHINE OXIDASE;

ANIMALIA;

EID: 33645216155     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0510352103     Document Type: Article

References (43)

1. Aderem, A. & Ulevitch, R. J. (2000) Nature 406, 782-787.
2. Medzhitov, R. (2001) Nat. Rev. Immunol. 1, 135-145.
3. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J. & Gusovsky, F. (1999) J. Biol. Chem. 274, 10689-10692.
4. Beutler, B. (2000) Curr. Opin. Microbiol. 3, 23-28.
5. Kadiiska, M. B., Mason, R. P., Dreher, K. L., Costa, D. L. & Ohio, A. J. (1997) Chem. Res. Toxicol. 10, 1104-1108.
6. Kadiiska, M. B., Ohio, A. J. & Mason, R. P. (2004) Spectrochim. Acta. A 60, 1371-1377.
7. Sato, K., Kadiiska, M. B., Ohio, A. J., Corbett, J., Fann, Y. C., Holland, S. M., Thurman, R. G. & Mason, R. P. (2002) FASEB J. 16, 1713-1720.
8. Arimoto, T., Kadiiska, M. B., Sato, K., Corbett, J. & Mason, R. P. (2005) Am. J. Respir. Crit. Care Med. 171, 379-387.
9. Nakamura, Y., Murakami, A., Ohto, Y., Torikai, K., Tanaka, T. & Ohigashi, H. (1998) Cancer Res. 58, 4832-4839.
10. Beak, S. M., Lee, Y. S. & Kim, J. A. (2004) Biochimie 86, 425-429.
11. Chamulitrat, W., Stremmel, W., Kawahara, T., Rokutan, K., Fujii, H., Wingler, K., Schmidt, H. H. H. W. & Schmidt, R. (2004) J. Invest. Dermatol. 122, 1000-1009.
12. Ceolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A. & Avogaro, A. (2004) Diabetes 53, 1344-1351.
13. Alam, A., Khan, N., Sharma, S., Saleem, M. & Sultana, S. (2002) Pharmacol. Res. 46, 557-564.
14. Deliconstantinos, G., Villiotou, V. & Stavrides, J. C. (1996) Biochem. Pharmacol. 51, 1727-1738.
15. Fujii, E., Yoshioka, T., Ishida, H., Irie, K & Muraki, T. (2000) Br. J. Pharmacol. 130, 90-94.
16. Iuvone, T., D'Acquisto, F., Van Osselaer, N., Di Rosa, M., Carnuccio, R. & Herman, A. G. (1998) Br. J. Pharmacol. 123, 1325-1330.
17. Yue Qian, S., Kadiiska, M. B., Guo, Q. & Mason, R. P. (2005) Free Radical Biol. Med. 38, 125-135.
18. Bochkov, V. N., Kadi, A., Huber, J., Gruber, F., Binder, B. R. & Leitinger, N. (2002) Nature 419, 77-81.
19. Porras, A. G., Olson, J. S. & Palmer, G. (1981) J. Biol. Chem. 256, 9096-9103.
20. Athar, M., Elmets, C. A., Bickers, D. R. & Mukhtar, H. (1989) J. Clin. Invest. 83, 1137-1143.
21. Sultana, S., Alam, A., Khan, N. & Sharma, S. (2003) Redox Rep. 8, 105-112.
22. Sultana, S., Khan, N., Sharma, S. & Alam, A. (2003) J. Ethnopharmacol. 85, 33-41.
23. Reiners, J. J., Jr., Pence, B. C., Barcus, M. C. & Cantu, A. R. (1987) Cancer Res. 47, 1775-1779.
24. Shimizu, S., Tanaka, H., Sakaki, S., Yukioka, T., Matsuda, H. & Shimazaki, S. (2002) J. Trauma 52, 683-687.
25. Moorhouse, P. C., Grootveld, M., Halliwell, B., Quinlan, J. G. & Gutteridge, J. M. C. (1987) FEBS Lett. 213, 23-28.
26. Jayson, G. G., Parsons, B. J. & Swallow, A. J. (1973) J. Chem. Soc. Faraday Trans. 69, 1597-1607.
27. Quintiliani, M., Badiello, R., Tamba, M., Esfandi, A. & Gorin, G. (1977) Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 32, 195-202.
28. Martin, H. M., Hancock, J. T., Salisbury, V. & Harrison, R. (2004) Infect. Immun. 72, 4933-4939.
29. Goldsmith, P. C., Leslie, T. A., Hayes, N. A., Levell, N. J., Dowd, P. M. & Foreman, J. C. (1996) J. Invest. Dermatol. 106, 113-118.
30. Roméro-Graillet, C., Aberdam, E., Clément, M., Ortonne, J. P. & Ballotti, R. (1997) J. Clin. Invest. 99, 635-642.
31. Bruch-Gerharz, D., Fehsel, K., Suschek, C., Michel, G., Ruzicka, T. & Kolb-Bachofen, V. (1996) J. Exp. Med. 184, 2007-2012.
32. Kuhn, A., Fehsel, K., Lehmann, P., Krutmann, J., Ruzicka, T. & Kolb-Bachofen, V. (1998) J. Invest. Dermatol. 111, 149-153.
33. Rowe, A., Farrell, A. M. & Bunker, C. B. (1997) Br. J. Dermatol. 136, 18-23.
34. Yamasaki, K., Edington, H. D. J., McClosky, C., Tzeng, E., Lizonova, A., Kovesdi, I., Steed, D. L. & Billiar, T. R. (1998) J. Clin. Invest. 101, 967-971.
35. Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., 1 Muller, W., Moncada, S. & Liew, F. Y. (1995) Nature 375, 408-411.
36. Millar, T. M. (2004) FEES Lett. 562, 129-133.
37. Augusto, O., Gatti, R. M. & Radi, R. (1994) Arch. Biochem. Biophys. 310, i 118-125.
38. Bonini, M. G., Radi, R., Ferrer-Sueta, G., Ferreira, A. M. D. C. & Augusto, O. (1999) J. Biol. Chem. 274, 10802-10806.
39. Goldstein, S., Czapski, G., Lind, J. & Merényi, G. (2001) Chem. Res. Toxicol. 14, 1273-1276.
40. Lymar, S. V. & Hurst, J. K. (1996) Chem. Res. Toxicol. 9, 845-850.
41. Nakai, K. & Mason, R. P. (2005) Free Radical Biol. Med. 39, 1050-1058.
42. Duling, D. R. (1994) J. Magn. Reson. B 104, 105-110.
43. Kosaka, H., Yoneyama, H., Zhang, L., Fujii, S., Yamamoto, A. & Igarashi, J. (2003) FASEB J. 17, 636-643.